Dillistone Group PLC
16 January 2008
This announcement replaces the version released at 9.16am this morning under RNS
number 8765L. Please note that this is to amend Alexander James's percentage
sign to <.
Dillistone Group Plc (the 'Company'), the AIM listed supplier of recruitment
software, was informed yesterday that certain of the directors have brought
ordinary 5p shares in the Company as follows:
Director Shares purchased Price per share
James McLaughlin 500 170p
Jason Starr 500 170p
Rory Howard 500 170p
Alexander James 500 170p
Accordingly, the new beneficial interests of those directors are as follows:
Director Beneficial interest in Percentage of issued
Ordinary 5p shares and voting share capital
James McLaughlin 993,933 18.4
Jason Starr 1,159,506 21.47
Rory Howard 1,159,506 21.47
Alexander James 1,700 <1
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.